Sweden· SE-20190814000045
Aurorix 150 mg Filmdragerad tablett
A medicinal product containing moclobemide, registered in Sweden by Ebb Medical AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Moclobemide
- Manufacturer
- Ebb Medical AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20190814000045
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Moclobemide in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAurorixViatris Oy
- PolandAurorixViatris Healthcare Sp. z o.o.
- BelgiumMoclobemide Mylan 150 mgViatris GX
- SwitzerlandAurorix 150
- CzechiaAURORIXVIATRIS HEALTHCARE LIMITED, Dublin
- NorwayAurorix2care4 ApS
- FranceMOCLAMINE 150 mg, comprimé pelliculé sécableBIOCODEX
- IrelandManerix 150 mg Film-coated TabletsViatris Healthcare Limited
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Aurorix
- Belgium · Moclobemide Sandoz
- Czechia · Aurorix
- Germany · Aurorix, Moclobemid 1 A Pharma
- Spain · Manerix
- Finland · Aurorix
- France · Moclamine
- United Kingdom (Northern Ireland) · Manerix, Moclobemide
- Hungary · Aurorix
- Ireland · Manerix
- Netherlands · Moclobemide Sandoz
- Norway · Aurorix
- Poland · Aurorix, Mobemid
- Portugal · Aurorix, Zorix
- Slovenia · Aurorix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/28920946-90b7-43d6-9de5-b4376bcdb0e7 GET /v1/drugs/28920946-90b7-43d6-9de5-b4376bcdb0e7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL"
],
"se_npl_id": "20190814000045",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20190814000045",
"product_doc_link": "https://docetp.mpa.se/LMF/Aurorix%20150%20mg%20film-coated%20tablet%20ES%20PL_09001bee807a3d6b.pdf"
}See everything about moclobemide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.